Granulocyte macrophage colony stimulating factor (GM-CSF) induced sero-protection in end stage renal failure patients to hepatitis B in vaccine non-responders

Renal Failure

Volumn 23, Issue 5, 2001, Pages 629-636

  Jha, R ^a   Lakhtakia, S ^a   Jaleel, M A ^a   Narayan, G ^a   Hemlatha, K ^a  

^a Medwin Hospital   (India)

Author keywords

Dialysis; GM CSF; Hepatitis B vaccine

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT HEPATITIS B VACCINE;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; DRUG RESPONSE; FEMALE; HEMODIALYSIS; HEPATITIS B; HUMAN; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; SIDE EFFECT; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ADULT; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; INDIA; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROBABILITY; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 0035173028     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-100107359     Document Type: Article

References (20)

1. Epidemiology of hepatitis B virus infection in India
2. Mortality due to HBV in hemodialysis, effect of vaccination
3. Hepatitis B infection in dialysis unit in South India
4. The impact of renal transplantation on the course of Hepatitis B liver disease
5. Active immunization against Hepatitis B infection of a hemodialysis population - Some problem
6. The dialysis vaccine trial group Hepatitis B vaccine in patients receiving hemodialysis. Immunogenicity and efficacy
7. Immunogenicity of recombinant Hepatitis B vaccine in dialysis patients
8. Hepatitis B vaccination - Now and in the future
9. Long term immunogenicity and efficacy of Hepatitis B vaccine in hemodialysis patients
10. Comparison of two schedules of hepatitis B vaccination in patients with mild, moderate and severe renal failure
11. Treatment with recombinant human erythropoietin increases antibody titres after hepatitis B vaccination in dialysis patients
12. Low dose interleukin-2 induces systemic immune responses against HBsAg in immunodeficient non-responders to hepatitis vaccination
13. The effect of granulocyte-macrophage colony - Stimulating factor (GM-CSF) on hepatitis B vaccination in hemodialysis patients
14. Seroconversion rate, hepatitis B vaccination, hemodialysis and zinc supplementation
15. Altered monocyte function in uremia
16. Defective lymphoproliferative responses and interleukin 2 production in chronic renal failure patients
17. Evaluation of tolerability and antibody response after recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine
18. Granulocyte macrophage colony stimulating factor as an adjuvant to persons not responding to hepatitis B vaccine
19. Role of granulocyte macrophage colony stimulating factor in hepatitis B vaccination in hemodialysis patients - Prospective trial
20. Effect of granuocyte macrophage colony stimulating factor on Hepatitis B vaccination in hemodialysis patients